ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)

Technical Analysis Report for NASDAQ stock BOLD Audentes Therapeutics. Dated: 04 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics

Audentes Therapeutics Opened at 2.87 and Closed at: 2.87, which is 0% of previous session's close. It moved within a range of 2.86 and 2.89
The session was a Neutral session with an average volume of 20000, which is -262% of previous session's volumes.

  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

Support for tomorrow is 2.86 and resistance for tomorrow is 2.89
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.86, 2.84 resistance for tomorrow's hourly charts is 2.89, 2.9

10 Day SMA for Audentes Therapeutics (BOLD) is 2.88 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Audentes Therapeutics (BOLD) is 2.86 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Audentes Therapeutics (BOLD) is 2.67 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 2.11 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Audentes Therapeutics is 1.65 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Audentes Therapeutics is at 2.86 and 200 DMA is at 1.65, while 50 DMA and 100 DMA are at 2.67 and 2.11 respectively

Audentes Therapeutics (BOLD) moving average of 20 SMA is at 2.86 and 20 EMA is at 2.83

Audentes Therapeutics (BOLD) moving average of 50 SMA is at 2.67 and 50 EMA is at 2.59

Audentes Therapeutics (BOLD) moving average of 100 SMA is at 2.11 and 100 EMA is at 2.27

Audentes Therapeutics (BOLD) moving average of 200 SMA is at 1.65 and 200 EMA is at 1.91

Vertex Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 2.49% more returns!

Audentes Therapeutics has performed better than Utah Medical in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Ultragenyx Pharmaceutical in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Minerva Neurosciences in short term. Holding Audentes Therapeutics could be a better choice for now!

Aceto Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Aceto Corporation, about 16.48% more returns!

Ac Immune has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Ac Immune, about 23.67% more returns!

Audentes Therapeutics has performed better than Aldeyra Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!

Altimmune Inc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Altimmune Inc, about 10.36% more returns!

Audentes Therapeutics has performed better than Accuray Incorporated in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Axogen Inc in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Diamedica Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!

Electrocore Inc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Electrocore Inc, about 1.02% more returns!

Audentes Therapeutics has performed better than Icu Medical in short term. Holding Audentes Therapeutics could be a better choice for now!

Kura Oncology has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Kura Oncology, about 32.75% more returns!

Audentes Therapeutics has performed better than Lakeland Industries in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Microbot Medical in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics Technical analysis of indicators

Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Audentes Therapeutics in short term but the sell signal is initial and weak.

Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Audentes Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.89 and Audentes Therapeutics BOLD stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.

Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And BOLD Experts View which covers a lot of information including buying and selling signals

BOLD future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here

Chart Audentes Therapeutics (BOLD)  Technical (Analysis) Reports Audentes Therapeutics [

Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Audentes Therapeutics (BOLD)  Technical (Analysis) Reports Audentes Therapeutics [

 

Back to top